Trademark Overview
On Thursday, February 26, 2026, a trademark application was filed for RARE DISEASE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RARE DISEASE THERAPEUTICS trademark a serial number of 99672556. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 26, 2026. This trademark is owned by Rare Disease Therapeutics, Inc.. The RARE DISEASE THERAPEUTICS trademark is filed in the Advertising, Business and Retail Services category with the following description:
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Marketing services; Sales promotion services; Market analysis
